1. Home
  2. ZLAB vs SKLZ Comparison

ZLAB vs SKLZ Comparison

Compare ZLAB & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • SKLZ
  • Stock Information
  • Founded
  • ZLAB 2013
  • SKLZ 2012
  • Country
  • ZLAB China
  • SKLZ United States
  • Employees
  • ZLAB N/A
  • SKLZ N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • SKLZ EDP Services
  • Sector
  • ZLAB Health Care
  • SKLZ Technology
  • Exchange
  • ZLAB Nasdaq
  • SKLZ Nasdaq
  • Market Cap
  • ZLAB 3.4B
  • SKLZ 136.4M
  • IPO Year
  • ZLAB 2017
  • SKLZ N/A
  • Fundamental
  • Price
  • ZLAB $32.80
  • SKLZ $7.14
  • Analyst Decision
  • ZLAB Buy
  • SKLZ Buy
  • Analyst Count
  • ZLAB 6
  • SKLZ 1
  • Target Price
  • ZLAB $57.22
  • SKLZ $14.00
  • AVG Volume (30 Days)
  • ZLAB 815.7K
  • SKLZ 71.3K
  • Earning Date
  • ZLAB 11-11-2025
  • SKLZ 11-06-2025
  • Dividend Yield
  • ZLAB N/A
  • SKLZ N/A
  • EPS Growth
  • ZLAB N/A
  • SKLZ N/A
  • EPS
  • ZLAB N/A
  • SKLZ N/A
  • Revenue
  • ZLAB $427,799,000.00
  • SKLZ $93,320,000.00
  • Revenue This Year
  • ZLAB $42.62
  • SKLZ $17.44
  • Revenue Next Year
  • ZLAB $55.12
  • SKLZ $12.03
  • P/E Ratio
  • ZLAB N/A
  • SKLZ N/A
  • Revenue Growth
  • ZLAB 32.56
  • SKLZ N/A
  • 52 Week Low
  • ZLAB $20.17
  • SKLZ $3.54
  • 52 Week High
  • ZLAB $44.34
  • SKLZ $9.11
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 48.82
  • SKLZ 37.95
  • Support Level
  • ZLAB $26.67
  • SKLZ $7.21
  • Resistance Level
  • ZLAB $32.11
  • SKLZ $7.54
  • Average True Range (ATR)
  • ZLAB 1.41
  • SKLZ 0.29
  • MACD
  • ZLAB 0.02
  • SKLZ -0.19
  • Stochastic Oscillator
  • ZLAB 69.83
  • SKLZ 3.67

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About SKLZ Skillz Inc.

Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

Share on Social Networks: